Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016

Date: June 29, 2016
Pages: 509
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S080D1978CEEN
Leaflet:

Download PDF Leaflet

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016

SUMMARY

GlobalData's clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016' provides an overview of Small-Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Small-Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Small-Cell Lung Cancer Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Small-Cell Lung Cancer
Jun 06, 2016: Immunomedics Announces Sacituzumab Govitecan (IMMU-132) is Active in Patients With Previously-Treated Metastatic Small-Cell Lung Cancer
Jun 05, 2016: Results of Phase 1a/1b Study of AbbVies Investigational Medicine Rovalpituzumab Tesirine (Rova-T) Showed Overall Response Rate of 39 Percent in Pretreated Patients with Biomarker-Defined Small Cell Lung Cancer (SCLC)
Jun 05, 2016: OncoMed Presents Phase 1b Data on tarextumab at the 2016 ASCO Annual Meeting
Jun 02, 2016: Two-drug immunotherapy deemed safe for lung cancer patients, Moffitt study shows
May 19, 2016: Immunomedics to Report Updated Results for Sacituzumab Govitecan (IMMU-132) in Breast and Lung Cancers at Clinical Science Symposia of 2016 ASCO Annual Meeting
May 04, 2016: MOLOGEN to present next generation of TLR9 agonists at ASGCT 2016
Apr 29, 2016: Immunomedics Reports Responses With Sacituzumab Govitecan (IMMU-132) in Patients With Metastatic Solid Cancers Who Failed Prior Checkpoint-Inhibitor Therapy
Apr 21, 2016: OncoMed Announces Updated Phase 1b Data for Tarextumab to be Presented at the 2016 ASCO Annual Meeting
Apr 18, 2016: AstraZeneca Presents Data on Next-generation Investigational Wee1 Inhibitor at the AACR 2016 Annual Meeting
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016
Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2016
Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016
Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016
Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2016
Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016
Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016

LIST OF FIGURES

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016
Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2016
Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016
Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016
Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2016
Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016
Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016
Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016
GlobalData Methodology

COMPANIES MENTIONED

GlaxoSmithKline Plc
AstraZeneca Plc
Novartis AG
Eli Lilly and Company
Bristol-Myers Squibb Company
AbbVie Inc.
Celgene Corporation
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Bayer AG
Skip to top


Ask Your Question

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: